IL6 and rheumatoid arthritis: Pharmacological inhibitors of IL-6 signaling, which are already used in the clinic to treat chronic disorders like rheumatoid arthritis, have been shown to induce beneficial effects in a suite of experimental models of degenerative diseases [42,85,86,87].